Skip to main content

Table 2 Change in Hgb, ferrtin and TSAT from baseline to 6 months by treatment group

From: Heme iron polypeptide for the treatment of iron deficiency anemia in non-dialysis chronic kidney disease patients: a randomized controlled trial

Parameter HIP baseline HIP 6 m p-value IV iron sucrose baseline IV iron sucrose 6 m p-value
Hgb 110.5 117 0.15 108.5 113 0.23
(104–119) (110–128.8)   (102–117) (107.5-120.3)  
Ferritin 71 85.5 0.81 67 244 0.003
(40–143) (44–104)   (27–100) (71.5-298)  
TSAT 17 21.5 0.05 16.5 21.5 0.04
  (14–20) (17–29)   (10–20) (17–27)